480 related articles for article (PubMed ID: 18425213)
1. Parallels between pathogens and gluten peptides in celiac sprue.
Bethune MT; Khosla C
PLoS Pathog; 2008 Feb; 4(2):e34. PubMed ID: 18425213
[TBL] [Abstract][Full Text] [Related]
2. Celiac disease: from pathogenesis to novel therapies.
Schuppan D; Junker Y; Barisani D
Gastroenterology; 2009 Dec; 137(6):1912-33. PubMed ID: 19766641
[TBL] [Abstract][Full Text] [Related]
3. Intestinal Barrier Function in Gluten-Related Disorders.
Cardoso-Silva D; Delbue D; Itzlinger A; Moerkens R; Withoff S; Branchi F; Schumann M
Nutrients; 2019 Oct; 11(10):. PubMed ID: 31581491
[TBL] [Abstract][Full Text] [Related]
4. Celiac disease: risk assessment, diagnosis, and monitoring.
Setty M; Hormaza L; Guandalini S
Mol Diagn Ther; 2008; 12(5):289-98. PubMed ID: 18803427
[TBL] [Abstract][Full Text] [Related]
5. Gluten: a two-edged sword. Immunopathogenesis of celiac disease.
Koning F; Gilissen L; Wijmenga C
Springer Semin Immunopathol; 2005 Sep; 27(2):217-32. PubMed ID: 16091925
[TBL] [Abstract][Full Text] [Related]
6. Similar Responses of Intestinal T Cells From Untreated Children and Adults With Celiac Disease to Deamidated Gluten Epitopes.
Ráki M; Dahal-Koirala S; Yu H; Korponay-Szabó IR; Gyimesi J; Castillejo G; Jahnsen J; Qiao SW; Sollid LM
Gastroenterology; 2017 Sep; 153(3):787-798.e4. PubMed ID: 28535873
[TBL] [Abstract][Full Text] [Related]
7. Structural basis for gluten intolerance in celiac sprue.
Shan L; Molberg Ø; Parrot I; Hausch F; Filiz F; Gray GM; Sollid LM; Khosla C
Science; 2002 Sep; 297(5590):2275-9. PubMed ID: 12351792
[TBL] [Abstract][Full Text] [Related]
8. Molecular and Structural Parallels between Gluten Pathogenic Peptides and Bacterial-Derived Proteins by Bioinformatics Analysis.
Vazquez DS; Schilbert HM; Dodero VI
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502187
[TBL] [Abstract][Full Text] [Related]
9. Oral enzyme therapy for celiac sprue.
Bethune MT; Khosla C
Methods Enzymol; 2012; 502():241-71. PubMed ID: 22208988
[TBL] [Abstract][Full Text] [Related]
10. [Molecular mechanisms behind the immunological reaction against gluten in patients with celiac disease].
Nielsen C; Husby S; Lillevang ST
Ugeskr Laeger; 2003 Feb; 165(9):917-20. PubMed ID: 12661516
[TBL] [Abstract][Full Text] [Related]
11. Understanding the molecular basis of celiac disease: what genetic studies reveal.
Monsuur AJ; Wijmenga C
Ann Med; 2006; 38(8):578-91. PubMed ID: 17438672
[TBL] [Abstract][Full Text] [Related]
12. Plasma Cells Are the Most Abundant Gluten Peptide MHC-expressing Cells in Inflamed Intestinal Tissues From Patients With Celiac Disease.
Høydahl LS; Richter L; Frick R; Snir O; Gunnarsen KS; Landsverk OJB; Iversen R; Jeliazkov JR; Gray JJ; Bergseng E; Foss S; Qiao SW; Lundin KEA; Jahnsen J; Jahnsen FL; Sandlie I; Sollid LM; Løset GÅ
Gastroenterology; 2019 Apr; 156(5):1428-1439.e10. PubMed ID: 30593798
[TBL] [Abstract][Full Text] [Related]
13. Noninflammatory gluten peptide analogs as biomarkers for celiac sprue.
Bethune MT; Crespo-Bosque M; Bergseng E; Mazumdar K; Doyle L; Sestak K; Sollid LM; Khosla C
Chem Biol; 2009 Aug; 16(8):868-81. PubMed ID: 19716477
[TBL] [Abstract][Full Text] [Related]
14. Physiopathology and Management of Gluten-Induced Celiac Disease.
Kumar J; Kumar M; Pandey R; Chauhan NS
J Food Sci; 2017 Feb; 82(2):270-277. PubMed ID: 28140462
[TBL] [Abstract][Full Text] [Related]
15. Duodenal Bacteria From Patients With Celiac Disease and Healthy Subjects Distinctly Affect Gluten Breakdown and Immunogenicity.
Caminero A; Galipeau HJ; McCarville JL; Johnston CW; Bernier SP; Russell AK; Jury J; Herran AR; Casqueiro J; Tye-Din JA; Surette MG; Magarvey NA; Schuppan D; Verdu EF
Gastroenterology; 2016 Oct; 151(4):670-83. PubMed ID: 27373514
[TBL] [Abstract][Full Text] [Related]
16. Combination enzyme therapy for gastric digestion of dietary gluten in patients with celiac sprue.
Gass J; Bethune MT; Siegel M; Spencer A; Khosla C
Gastroenterology; 2007 Aug; 133(2):472-80. PubMed ID: 17681168
[TBL] [Abstract][Full Text] [Related]
17. Transglutaminase 2-targeted autoantibodies in celiac disease: Pathogenetic players in addition to diagnostic tools?
Lindfors K; Mäki M; Kaukinen K
Autoimmun Rev; 2010 Sep; 9(11):744-9. PubMed ID: 20547248
[TBL] [Abstract][Full Text] [Related]
18. T-cell response to gluten in patients with HLA-DQ2.2 reveals requirement of peptide-MHC stability in celiac disease.
Bodd M; Kim CY; Lundin KE; Sollid LM
Gastroenterology; 2012 Mar; 142(3):552-61. PubMed ID: 22108197
[TBL] [Abstract][Full Text] [Related]
19. The immunopathogenesis of celiac disease reveals possible therapies beyond the gluten-free diet.
McAllister CS; Kagnoff MF
Semin Immunopathol; 2012 Jul; 34(4):581-600. PubMed ID: 22674144
[TBL] [Abstract][Full Text] [Related]
20. Celiac disease: from gluten to autoimmunity.
Briani C; Samaroo D; Alaedini A
Autoimmun Rev; 2008 Sep; 7(8):644-50. PubMed ID: 18589004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
